SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
FRA:SHL - Deutsche Boerse Ag - DE000SHL1006 - Common Stock - Currency: EUR
Taking everything into account, SHL scores 5 out of 10 in our fundamental rating. SHL was compared to 57 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
In the past 5 years SHL has always been profitable.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
SHL's Return On Assets of 4.45% is fine compared to the rest of the industry. SHL outperforms 68.42% of its industry peers.
Looking at the Return On Equity, with a value of 11.19%, SHL is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
SHL's Return On Invested Capital of 7.37% is fine compared to the rest of the industry. SHL outperforms 71.93% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 8.08%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.45% | ||
| ROE | 11.19% | ||
| ROIC | 7.37% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
With a decent Profit Margin value of 9.03%, SHL is doing good in the industry, outperforming 68.42% of the companies in the same industry.
SHL's Profit Margin has declined in the last couple of years.
SHL has a better Operating Margin (13.67%) than 68.42% of its industry peers.
In the last couple of years the Operating Margin of SHL has declined.
With a Gross Margin value of 38.77%, SHL is not doing good in the industry: 75.44% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.67% | ||
| PM (TTM) | 9.03% | ||
| GM | 38.77% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
Compared to 1 year ago, SHL has more shares outstanding
Compared to 5 years ago, SHL has more shares outstanding
SHL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.96 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL has a Altman-Z score of 1.96. This is comparable to the rest of the industry: SHL outperforms 49.12% of its industry peers.
SHL has a debt to FCF ratio of 6.06. This is a slightly negative value and a sign of low solvency as SHL would need 6.06 years to pay back of all of its debts.
SHL's Debt to FCF ratio of 6.06 is in line compared to the rest of the industry. SHL outperforms 56.14% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.65) is worse than 71.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.06 | ||
| Altman-Z | 1.96 |
ROIC/WACC1.25
WACC5.88%
2.3 Liquidity
A Current Ratio of 1.10 indicates that SHL should not have too much problems paying its short term obligations.
SHL has a Current ratio of 1.10. This is in the lower half of the industry: SHL underperforms 71.93% of its industry peers.
SHL has a Quick Ratio of 1.10. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.76. This is in the lower half of the industry: SHL underperforms 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.12% over the past year.
SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 5.83% in the last year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)5.12%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%1.82%
Revenue 1Y (TTM)5.83%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%8.72%
3.2 Future
The Earnings Per Share is expected to grow by 10.21% on average over the next years. This is quite good.
SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.64% yearly.
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y10.21%
Revenue Next Year5.7%
Revenue Next 2Y5.9%
Revenue Next 3Y6.04%
Revenue Next 5Y5.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.39, SHL is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 82.46% of the companies listed in the same industry.
SHL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.15, the valuation of SHL can be described as correct.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 75.44% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, SHL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.39 | ||
| Fwd PE | 16.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 71.93% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaply inside the industry as 87.72% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.7 | ||
| EV/EBITDA | 15.4 |
4.3 Compensation for Growth
SHL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of SHL may justify a higher PE ratio.
SHL's earnings are expected to grow with 12.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.67
PEG (5Y)2.8
EPS Next 2Y13.11%
EPS Next 3Y12.78%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.07, SHL pays a better dividend. On top of this SHL pays more dividend than 85.96% of the companies listed in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
101.91% of the earnings are spent on dividend by SHL. This is not a sustainable payout ratio.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP101.91%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
FRA:SHL (7/11/2025, 7:00:00 PM)
46.08
-1.77 (-3.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.98B
Analysts83.7
Price Target62.21 (35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP101.91%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.12%
Min EPS beat(2)-2.04%
Max EPS beat(2)8.28%
EPS beat(4)2
Avg EPS beat(4)2.45%
Min EPS beat(4)-2.04%
Max EPS beat(4)8.28%
EPS beat(8)5
Avg EPS beat(8)1.99%
EPS beat(12)7
Avg EPS beat(12)1.43%
EPS beat(16)10
Avg EPS beat(16)3.47%
Revenue beat(2)2
Avg Revenue beat(2)0.78%
Min Revenue beat(2)0.27%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.42%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)-1.73%
PT rev (3m)-3.21%
EPS NQ rev (1m)-3.59%
EPS NQ rev (3m)-9.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-3.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.39 | ||
| Fwd PE | 16.15 | ||
| P/S | 2.25 | ||
| P/FCF | 18.7 | ||
| P/OCF | 14.67 | ||
| P/B | 2.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.4 |
EPS(TTM)2.26
EY4.9%
EPS(NY)2.85
Fwd EY6.19%
FCF(TTM)2.46
FCFY5.35%
OCF(TTM)3.14
OCFY6.82%
SpS20.52
BVpS16.55
TBVpS-5.76
PEG (NY)1.67
PEG (5Y)2.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.45% | ||
| ROE | 11.19% | ||
| ROCE | 9.41% | ||
| ROIC | 7.37% | ||
| ROICexc | 8.05% | ||
| ROICexgc | 44.05% | ||
| OM | 13.67% | ||
| PM (TTM) | 9.03% | ||
| GM | 38.77% | ||
| FCFM | 12.01% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.06 | ||
| Debt/EBITDA | 2.78 | ||
| Cap/Depr | 62.49% | ||
| Cap/Sales | 3.3% | ||
| Interest Coverage | 7.53 | ||
| Cash Conversion | 80.8% | ||
| Profit Quality | 133.08% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | 1.96 |
F-Score8
WACC5.88%
ROIC/WACC1.25
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.12%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%1.82%
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y10.21%
Revenue 1Y (TTM)5.83%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%8.72%
Revenue Next Year5.7%
Revenue Next 2Y5.9%
Revenue Next 3Y6.04%
Revenue Next 5Y5.64%
EBIT growth 1Y21.23%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.59%
FCF growth 1Y102.62%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y57.68%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%